PubMed=8409397; DOI=10.4049/jimmunol.151.8.4209
Dolores Jean Schendel, Bernd Gansbacher, Ralph Oberneder, Martin Kriegmair, Alfons Georg Hofstetter, Gert Riethmuller, Oscar G. Segurado;
Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines.
J. Immunol. 151:4209-4220(1993)

PubMed=11175312; DOI=10.1038/sj.gt.3301349
Dolores Jean Schendel, Bernhard Frankenberger, Petra Jantzer, Sophie Cayeux, Elfriede Noessner, Gerald Willimsky, Barbara Maget, Heike Pohla, Thomas Blankenstein;
Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse.
Gene Ther. 7:2007-2014(2000)

PubMed=11809699
Christine S. Falk, Elfriede Noessner, Elisabeth H. Weiss, Dolores Jean Schendel;
Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells.
Cancer Res. 62:480-487(2002)

PubMed=15755994; DOI=10.1158/1078-0432.CCR-04-1883
Bernhard Frankenberger, Heike Pohla, Elfriede Noessner, Gerald Willimsky, Britta Papier, Antonio Pezzutto, Joachim Kopp, Ralph Oberneder, Thomas Blankenstein, Dolores Jean Schendel;
Influence of CD80, interleukin-2, and interleukin-7 expression in human renal cell carcinoma on the expansion, function, and survival of tumor-specific CTLs.
Clin. Cancer Res. 11:1733-1742(2005)

PubMed=15997395; DOI=10.1007/s00345-005-0505-5
Bernhard Frankenberger, Sybille Regn, Christiane Geiger, Elfriede Noessner, Christine S. Falk, Heike Pohla, Miran Javorovic, Tobias Silberzahn, Susanne Wilde, Alexander Buchner, Michael Siebels ...Show all 16 authors... , Ralph Oberneder, Gerald Willimsky, Antonio Pezzutto, Thomas Blankenstein, Dolores Jean Schendel; Show fewer authors
Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells.
World J. Urol. 23:166-174(2005)

PubMed=16045799; DOI=10.1186/1479-5876-3-29; PMCID=PMC1188079
Christiane Geiger, Sybille Regn, Andreas Weinzierl, Elfriede Noessner, Dolores Jean Schendel;
A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma.
J. Transl. Med. 3:29.1-29.15(2005)

PubMed=16261161; DOI=10.1038/sj.onc.1209188
Roghieh Djafarzadeh, Elfriede Noessner, Hartmut Engelmann, Dolores Jean Schendel, Mike Notohamiprodjo, Irene von Luettichau, Peter J. Nelson;
GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing.
Oncogene 25:1496-1508(2006)